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The kinetics of lymph node and systemic uptake of members of three different classes of lympho- 
scintigraphic agents were studied in normal laboratory rats. 
*“Tc human serum albumin (TcHSA), 
99mTc antimony trisulfide colloid (TcSbC), 
12’1 SG6.4 (a murine IgGZak monoclonal antibody), izrI 763.24T 
(a murine IgG,), and ‘*‘I FT166 (a murine IgM monoclonal) all current or potential lymphoscintigraphic 
agents, were injected subcutaneously into the hind foot pads of healthy rats. Ipsilateral and contralateral 
popliteal lymph nodes were sampled up to 4 h post-injection. Subcutaneous injection resulted in far higher 
nodal uptake for all agents than i.v. delivery with ipsilateral popliteal node/blood ratios 1 h post- 
subcutaneous injection of: for TcSbC (1900) > ‘*9 IgM (497) > TcHSA (72) > ‘*‘I Intact IgG2a or lz51 
IgG, at approximately 10. Thus, while all agents achieve popliteal node/blood ratios far greater than unity, 
TcSbc has the greatest absolute and relative nodal accumulation, greater than the “‘1 IgM monoclonal 
antibody and TcHSA. Uptake of the intact lzsI IgG antibodies is lowest. These data suggest that TcSbC 
in particular, as well as TcHSA and IgM may be most useful as non-specific node1 imaging agents, while 
the lower background activity of the IgGs may make targeting specific antigen in nodes more feasible. 
Introduction 
Lymphoscintigraphy, the intradermal or subcutaneous 
injection of a radiocolloid, has become an increas- 
ingly common technique in the past several years for 
mapping potential sites of nodal metastases and for 
predicting involvement with tumor (Croll et al., 1983). 
A considerable number of agents have been evaluated 
as possible lymphoscintigraphic agents (Bergvist et 
al., 1983). 99mTc antimony trisulfide colloid ((TcSbC) 
has been used extensively clinically, while we have 
more recently been using %Tc human serum albumin 
(TcHSA) for scanning (Croll et al., 1983; Froelich et 
al., 1984; Eberbach et al., 1987). Radiolabeled anti- 
bodies, and most recently monoclonal antibodies 
have also been suggested as potentially useful 
imaging agents and have shown promising results in 
animal models and in some clinical trials (DeLand 
et al., 1980; Weinstein et al., 1983; Carrasquillo et al., 
1986; Wahl et al., 1987). 
*All correspondence should be addressed to: Richard 
L. Wahl, M.D., University of Michigan Medical Center, 
Division of Nuclear Medicine, 1500 East Medical Center 
Drive, Ann Arbor, MI 48109-0028, U.S.A. 
While some information is available regarding 
the rate of egress of monoclonal antibodies injected 
subcutaneously, little is known regarding the kinetics 
of uptake of these agents into normal lymph nodes 
or if the larger IgM is handled differently (Bergqvist 
et al., 1983; Wahl et al., 1985). Similarly, relatively 
little is known regarding comparisons of non- 
colioidal TcHSA, which has been clinically useful in 
our practice, with the TcSbC product available for 
investigational use in the U.S. (Bergqvist et al., 1983; 
Eberbach et al., 1987). In fact, we have recently 
demonstrated that small molecules such as %Tc 
MDP used for bone scanning can reach relatively 
high levels in regional lymph nodes (following S.C. 
administration) suggesting that the colloidal state 
may not be a necessary prerequisite to achieving 
significant levels of uptake of radiopharmaceuticals 
to regional lymph nodes as has heen previously 
suggested (Croll et al., 1983; Wallis et al., 1987). This 
study was designed to delineate the rate and extent of 
lymph node and systemic uptake of these current and 
potential lymphoscintigraphic agents. 
Methods 
The lymphoscintigraphic agents studied included: 
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TcSbC LYMPHOSCINTIGRAPHIC AGENTS 
This agent, supplied in kit form by Cadema, was 
prepared by adding 10-15 mCi of [99mTc]pertech- 
netate to a kit supplied by Cadema. Fifty to 100 PCi 
was given per animal. Purity of over 90% was typical 
by acetone silica gel thin layer chromatography 
(Gelman, Ann Arbor, Mich.). 
I- 
Tc99mAntimrmy Colloid - 
FTl66 I IgM) ______ 
Tc66m HumanSerum Albumin ~~.~~~~.~..~ 
763.24T I lgG,l -.-.-. 
5G6.4(lgG2,) .._..-.._ 
TcHSA 
This was made by adding 4 mCi of 99mT~ to 7 mg 
of human serum albumin. This was provided in kit 
form by Medi-Physics. This reagent was 98% devoid 
of free TcO; by acetone silica gel thin layer chroma- 
tography (Gelman, Ann Arbor, Mich.). One hundred 
PCi was given per animal (approximately 7Opg). 
566.4 
566.4 is a murine IgG2ak reactive with ovarian 
and other epithelial carcinomas (Wahl et al., 1986). 
This agent was labeled using the iodogen method in 
which 1OOpg was reacted with 1 mCi of lz51 (ICN). 
Yields of over 70% were typical, with >95% purity 
following Biogel (Biorad) P-60 chromatography. 
Nine to ten PCi were given per animal. 
Similar iodination conditions were used for FT166, 
a murine IgM reactive with bladder carcinomas 
(4-5 PCi injected per animal) (Liebert), and 763.24T 
(10-l 1 PCi injected per animal), a murine IgGlk 
(Wilson et al., 1982). The purity of these antibodies 
was confirmed by SDS polyacrylamide gel electro- 
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Fig. 1. Semi-log plot of the uptake of five possible lympho- 
scintigraphic agents over time to the popliteal lymph 
nodes. Injections were all made subcutaneously to the hind 
foot pad. 
Adult, female Sprague Dawley rats were selected 
for study. All lymphoscintigraphic agent injections 
were made either intravenously by the femoral vein or 
subcutaneously into one hind foot pad. Animals were 
studied in groups of 3-7. Injection volumes were 
1OOpL or less. Tissues, including popliteal lymph 
nodes (ipsilateral and contralateral), ipsilateral and 
contralateral inguinal lymph nodes, blood, liver and 
lower leg muscle were obtained at selected intervals 
post-injection, weighted and counted using standard 
tissue processing techniques (Wahl et al., 1984). 
Radioactive decay was corrected for and the results 
were expressed as % kg-injected dose/g. Lymph 
node/blood ratios were determined by dividing lymph 
node uptake (X kg dose/g) by blood uptake (% kg 
dose/g). 763.24T and FT166 were studied following 
S.C. administration only. 
Following i.v. administration, there is high accumu- 
lation of TcSbC in the liver and spleen, compatible 
with the typical behavior of colloid (Table 1). Ipsi- 
lateral popliteal node/blood ratios reached 4070/l by 
4 h after S.C. injection. 
*Tc HSA 
Statistical analysis was by the Student’s t test and 
analysis of variance methods. 
Results 
‘%Tc antimony trisuljide colloid 
At 10 min following the injection of TcHSA, 
popliteal node uptake was 12.359 + 0.61, with a 
node/blood ratio of 220.7. The absolute uptake in the 
right popliteal node increased to peak at 1 h (18.24 
f 7.53), and then fell to 9.33 + 2.16 by 4 h post- 
injection. The popliteal node/blood ratio also fell to 
38.3/l by 4 h post-injection (Fig. 1 and Table 2). 
Blood levels were considerably higher than for TcSbC 
following S.C. administration. Note that liver uptake 
following i.v. administration is considerably less than 
for antimony colloid. When TcHSA was given by the 
i.v. route, in contrast to the S.C. route, only minimal 
uptake was seen in popliteal lymph nodes (Table 2). 
From 30 min until 4 h after the injection of TcSbC, 
there was a dramatic increase in the uptake of the 
agent in the ipsilateral popliteal nodes. By 4 h, the 
percent kg-dose/g was 231.6 + 40.2 (SD) (Fig. 1). 
When given intravenously, the same dose of TcSbC 
produced nodal uptake of 0.0551 + 0.0106 (Table 1). 
lzsI 5G6.4 (intact &G.&k) 
This agent behaved in a similar fashion to TcHSA, 
in that nodal uptake ipsilateral to the injected foot 
peaked early and then declined. Maximal node/blood 
ratios were achieved soon after injection as well. 
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Table 4. “‘1 763.24T (IgG,) 
20 mill Ih 2h 4h 
Ipsilateral popliteal node 15.82 5 2.73 1.86 f 2.99 7.60 + 1.58 2.82 +_ 0.40 
Contralateral popliteal node 0.058 k 0.027 0.057 + 0.020 0.085 + 0.026 0.052 f 0.008 
Ipsilateral femoral node 1.34+ 1.32 0.426 f 0.247 0.239 kO.180 0.584 + 0.328 
Contralateral femoral node 0.033 If: 0.006 0.031 f 0.008 0.036 f 0.001 0.048 f 0.003 
Liver 0.03 f 0.007 0.089 f 0.004 0.130 50.012 0.152 i-O.015 
Blood 0. I90 + 0.042 0.484 i 0.044 0.682 + 0.088 0.761 + 0.190 
lpsilateral leg muscle 0.005 f 0.000 0.006 f 0.001 0.009 f 0.002 0.01 I + 0.002 
Contralateral leg muscle 0.033 k 0.006 0.007 * 0.001 0.008 + 0.000 0.011 * 0.002 
All organ uptakes are expressed as % kg-injected dose/g + I SD (following SC. administration to a hind foot 
pad) 
6.1/l at 4 h post-injection (Table 3). Absolute pop- 
liteal node activity also dropped with time. At 20 min 
post “‘1 566.4 injection the ipsilateral popliteal node 
activity was 8.81 f 1.30, but fell to 2.24 f 0.43 at 4 h 
after injection. 
I251 763.24T (IgGIk) 
This 150,000 dalton mouse monoclonal behaved 
very similarly to the ‘25I 566.4 antibody. At 20 min 
post-s.c. injection 15.82 + 2.73% kg-dose/g was 
located within the ipsilateral popliteal lymph node, 
while by 4 h post-injection, this had dropped to 2.82 
+ 0.40. Ipsilateral popliteal node/blood ratios fell 
from 83.4/l to 3.71/l at 4 h post-injection (Table 4). 
12’1 FT166 (ZgM) 
This 900,000 dalton mouse monoclonal behaved 
differently from the ‘*‘I IgG’s in terms of nodal 
uptake. For example, at 20min after S.C. injection, 
the ipsilateral popliteal node harbored 102.1 + 40.3% 
kg-dose/g and at 4 h still retained 32.4 + 6.4% kg- 
dose/g (Fig. 1). Ipsilateral node/blood ratios also 
were much higher than with the ‘25I IgG antibodies, 
with node/blood ratios of 1173/l at 20 min, and 
224.7/l at 4 h post-injection (Table 5). 
Discussion 
Our study compares several diverse colloidal and 
non-colloidal lymphoscintigraphic agents in the same 
animal system. These data shows that TcSbC is taken 
up to a much higher level in lymph nodes than are ‘25I 
IgG antibodies or TcHSA. In fact, node/blood ratios 
in excess of several thousand are seen with TcSbC. 
The ‘*‘I IgM, FT166, is taken up in the popliteal 
nodes far more than TcHSA or either the ‘*‘I IgG, or 
the ‘25I IgG2a intact antibodies. At early time points, 
the ‘25I IgM has slightly higher nodal uptake than the 
TcSbC. The TcHSA has a behavior intermediate be- 
tween the ‘*‘I IgM and the ‘*‘I IgG’s. This was some- 
what surprising, in that monomeric allumin would 
have a molecular weight in the 70,000 range, smaller 
than an intact antibody and might be expected to be 
less highly retained than the larger IgG’s. Radio- 
chromatographic TSK 3000 HPLC tracings of the 
TcHSA product we use routinely show an elution 
volume slightly greater than that of IgG, in the range 
expected for monomeric albumin. This indicates that 
the TcHSA is not aggregated into a larger moiety. 
The 12’1 IgG antibodies, an IgG2a 566.4 (reactive 
with ovarian cancer) (Wahl et al., 1986) and the IgG, 
763.24T (reactive with melanoma) (Wilson et al., 
1982) both have kappa light chains, and both behave 
similarly in vivo. While non-specific uptake of anti- 
bodies has been described in human imaging studies, 
the non-specific retention of these IgG agents appears 
relatively low, as at 4 h the popliteal nodes had 
less than l/lOOth the uptake that antimony colloid 
possessed (Carrasquillo et al., 1986; Engelstad et al., 
1986). TcHSA was retained to a higher degree than 
the ‘25I IgG antibody in the nodes. The mechanism 
for these differences is unclear at present. Certainly, 
some antibody binding to lymph nodes could be due 
to F-C receptor binding to mononuclear cells in the 
node, however the reason for higher TcHSA uptake 
is unclear (Hopf et al., 1976). 
Presumedly, much of the activity we see in lymph 
nodes over time is related to transient passage of the 
‘25I IgG antibodies through the nodes. The TcSbC 
appears to be actively sequestered by nodes, while 
the lz51 IgM and TcHSA appear to be taken up and 
retained to a greater extent than the intact lz51 IgG’s. 
These differences in uptake kinetics suggest that for 
delayed imaging of small lymph nodes, TcSbC would 
Table 5. ‘*‘I FT166 (IgM) 
20 min Ih 2h 4h 
Ipsilateral popliteal node 102.07 f 40.3 64.20 f 3.76 62.93 + 17.63 32.35 k 6.45 
Contralateral popliteal node 0.128 f 0.077 0.051 f 0.008 0.243 0.158 f 0.056 f 0.008 
Ipsilateral femoral node 0.387 + 0.201 2.08 + I .57 0.785 + 0.659 0.111 kO.036 
Contralateral femoral node 0.074 k 0.042 0.051 $- 0.01 I 0.0676 0.028 f 0.044 + 0.006 
Liver 0.037 f 0.003 0.061 + 0.006 0.050 0.006 f 0.045 * 0.004 
Blood 0.087 f 0.003 0.129 fO.O1O 0.134~0.015 0.144 f 0.015 
Ipsilateral leg muscle 0.008 + 0.001 0.015 f 0.002 0.015 f 0.003 0.013 f0.002 
Contralateral leg muscle 0.006 f 0.0002 0.013 + 0.001 0.014 0.002 f 0.012 f 0.001 
All organ uptakes are expressed as % kg-injected dose/g + I SD (following SC. administration to a hind food pad). 
LEFT LATERAL POSTERIOR 
Fig. 2. Left lateral and posterior gamma camera images from approximately 20 min post-injection of 
4 mCi of TcHSA about the excisional biopsy site of an anterior scalp melanoma. Note the multiple 
drainage routes shown on this image. The injection site is shielded with lead. 
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be the agent of choice. Despite the higher node/ mental observations should be useful in rationally 
background ratios for TcSbC, TcHSA in our hands planning clinical and experimental studies with 
has produced clinically usable lymphoscintigrams of lymphoscintigraphic agents. 
high quality at very early time points (minutes follow- 
ing injection) in patients. While node/blood ratios Acknowledgements-Thanks to Mr Steven Kronberg, Mr 
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lent clinical images at early times indicate it has 
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